{"id":3514,"date":"2025-09-05T16:49:50","date_gmt":"2025-09-05T07:49:50","guid":{"rendered":"https:\/\/atlas.ncc.go.jp\/member_search\/3514"},"modified":"2025-09-05T16:49:50","modified_gmt":"2025-09-05T07:49:50","slug":"%e7%99%bd%e5%b7%9d%e3%80%80%e5%a5%88%e7%be%8e","status":"publish","type":"researcher","link":"https:\/\/atlas.ncc.go.jp\/en\/member_search\/3514","title":{"rendered":"Nami Shirakawa EN"},"template":"","class_list":["post-3514","researcher","type-researcher","status-publish","hentry","en-US"],"acf":{"name_eg":"Nami SHIRAKAWA","familyName_eg":"Shirakawa","has_jp_name":true,"name_jp":"\u767d\u5ddd\u3000\u5948\u7f8e","researcher_photo":1258,"participated_in":["1"],"degree":"MD, PhD","position":"Department of Pediactric Oncology, Researcher","eg_position":"Department of Pediactric Oncology, Researcher","facilities":3399,"department":["24"],"speciality":"","eg_speciality":"","background":"<h2><strong>Dr. Shirakawa's Story<\/strong><\/h2>\r\n<p>I have been providing cancer treatment for children and AYAs at the National Cancer Center Hospital. The development of new drugs for pediatric oncology has been slow due to the fact that pediatric oncology is a rare cancer and drug metabolism is different from that of adults. Currently, I am involved in the development of new drugs so that more children can receive them. I am also interested in conducting research in cooperation with overseas countries to eliminate drug lag.<\/p>\r\n<h2><strong>Research Interest<\/strong><\/h2>\r\n<p>New drug development for pediatric oncology, international collaborative research in the pediatric field<\/p>\r\n<h2><strong>Professional Experience<\/strong><\/h2>\r\n<table class=\"table1\" style=\"border-collapse: collapse; width: 100%; height: 141px;\">\r\n<tbody>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 22.2887%; height: 11px;\">2022-present<\/td>\r\n<td style=\"width: 77.5977%; height: 11px;\">National Cancer Center Hospital, Clinical Research Support Office\/Department of Pediactric Oncology,\u00a0<\/td>\r\n<\/tr>\r\n<tr style=\"height: 10px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">2017~2022<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">National Cancer Center Hospital, Department of Pediactric Oncology<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2>Qualifications, certified physicians, medical specialists<\/h2>\r\n<p>Board Certified Pediatrician<\/p>\r\n<p>Diplomate, Subspecialty Board of Medical Oncology<\/p>\r\n<p>General Clinical Oncologist<\/p>","eg_background":"<h2><strong>Dr. Shirakawa's Story<\/strong><\/h2>\r\n<p>I have been providing cancer treatment for children and AYAs at the National Cancer Center Hospital. The development of new drugs for pediatric oncology has been slow due to the fact that pediatric oncology is a rare cancer and drug metabolism is different from that of adults. Currently, I am involved in the development of new drugs so that more children can receive them. I am also interested in conducting research in cooperation with overseas countries to eliminate drug lag.<\/p>\r\n<h2><strong>Research Interest<\/strong><\/h2>\r\n<p>New drug development for pediatric oncology, international collaborative research in the pediatric field<\/p>\r\n<h2><strong>Professional Experience<\/strong><\/h2>\r\n<table class=\"table1\" style=\"border-collapse: collapse; width: 100%; height: 141px;\">\r\n<tbody>\r\n<tr style=\"height: 48px;\">\r\n<td style=\"width: 22.2887%; height: 11px;\">2022-present<\/td>\r\n<td style=\"width: 77.5977%; height: 11px;\">National Cancer Center Hospital, Clinical Research Support Office\/Department of Pediactric Oncology,\u00a0<\/td>\r\n<\/tr>\r\n<tr style=\"height: 10px;\">\r\n<td style=\"width: 22.2887%; height: 10px;\">2017~2022<\/td>\r\n<td style=\"width: 77.5977%; height: 10px;\">National Cancer Center Hospital, Department of Pediactric Oncology<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<h2>Qualifications, certified physicians, medical specialists<\/h2>\r\n<p>Board Certified Pediatrician<\/p>\r\n<p>Diplomate, Subspecialty Board of Medical Oncology<\/p>\r\n<p>General Clinical Oncologist<\/p>","researcher_outerlink1":"","researcher_outerlink2":"","researcher_outerlink3":"","researcher_outerlink4":"","researcher_outerlink5":"","is_retired":false},"_links":{"self":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher\/3514","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/researcher"}],"about":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/types\/researcher"}],"acf:post":[{"embeddable":true,"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/facility\/3399"}],"wp:attachment":[{"href":"https:\/\/atlas.ncc.go.jp\/wp-json\/wp\/v2\/media?parent=3514"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}